PHARMAPLUS INVEST: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMAPLUS INVEST
Largest movements
- Intangible fixed assets -€52,071
down €52,071 (-24.9%), from €208,712 to €156,641
- Receivables within one year +€32,303
up €32,303 (+32.1%), from €100,553 to €132,856
of which Trade receivables: +€23,624
- Stocks and contracts -€20,985
down €20,985 (-14.8%), from €141,397 to €120,411
- Cash +€13,278
up €13,278 (+2.6%), from €515,234 to €528,512
mainly Other debts (+€87,706) and Depreciation (+€62,422)
- Profit (loss) carried forward -€90,147
down €90,147 (-69.4%), from €129,881 to €39,734
- Other debts +€87,706
up €87,706 (+17.1%), from €512,606 to €600,312
- Debts after one year -€51,734
down €51,734 (-24.3%), from €212,560 to €160,826
- Trade debts +€16,909
up €16,909 (+32.3%), from €52,420 to €69,329
- Write-downs +€27,997
new in 2025: €27,997
- Staff costs +€14,072
up €14,072 (+23.9%), from €58,983 to €73,055
- Taxes -€8,043
down €8,043 (-18.8%), from €42,706 to €34,663
- Gross operating margin +€4,840
up €4,840 (+1.8%), from €269,261 to €274,101
- Financial charges -€3,338
down €3,338 (-16.0%), from €20,908 to €17,570
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,007,458 | €976,007 | -€31,451 | -3.1% |
| Fixed assets | 21/28 | €249,003 | €189,954 | -€59,049 | -23.7% |
| Intangible fixed assets | 21 | €208,712 | €156,641 | -€52,071 | -24.9% |
| Tangible fixed assets | 22/27 | €37,704 | €30,726 | -€6,979 | -18.5% |
| Plant, machinery and equipment | 23 | €2,127 | €3,670 | +€1,543 | +72.6% |
| Furniture and vehicles | 24 | €35,577 | €27,055 | -€8,522 | -24.0% |
| Financial fixed assets | 28 | €2,587 | €2,587 | = | 0.0% |
| Current assets | 29/58 | €758,455 | €786,053 | +€27,599 | +3.6% |
| Stocks and contracts in progress | 3 | €141,397 | €120,411 | -€20,985 | -14.8% |
| Stocks | 30/36 | €141,397 | €120,411 | -€20,985 | -14.8% |
| Amounts receivable within one year | 40/41 | €100,553 | €132,856 | +€32,303 | +32.1% |
| Trade receivables | 40 | €86,601 | €110,225 | +€23,624 | +27.3% |
| Other amounts receivable | 41 | €13,952 | €22,631 | +€8,679 | +62.2% |
| Cash at bank and in hand | 54/58 | €515,234 | €528,512 | +€13,278 | +2.6% |
| Deferred charges and accrued income | 490/1 | €1,271 | €4,274 | +€3,003 | +236% |
| Total equity and liabilities | 10/49 | €1,007,458 | €976,007 | -€31,451 | -3.1% |
| Equity | 10/15 | €162,881 | €72,734 | -€90,147 | -55.3% |
| Contributions | 10/11 | €30,000 | €30,000 | = | 0.0% |
| Reserves | 13 | €3,000 | €3,000 | = | 0.0% |
| Distributable reserves | 133 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €129,881 | €39,734 | -€90,147 | -69.4% |
| Amounts payable | 17/49 | €844,576 | €903,273 | +€58,697 | +6.9% |
| Amounts payable after more than one year | 17 | €212,560 | €160,826 | -€51,734 | -24.3% |
| Financial debts | 170/4 | €212,560 | €160,826 | -€51,734 | -24.3% |
| Amounts payable within one year | 42/48 | €627,426 | €742,447 | +€115,021 | +18.3% |
| Current portion of amounts payable after more than one year | 42 | €50,818 | €56,324 | +€5,506 | +10.8% |
| Trade debts | 44 | €52,420 | €69,329 | +€16,909 | +32.3% |
| Suppliers | 440/4 | €52,420 | €69,329 | +€16,909 | +32.3% |
| Taxes, remuneration and social security | 45 | €11,581 | €16,482 | +€4,901 | +42.3% |
| Taxes | 450/3 | €4,689 | €6,835 | +€2,146 | +45.8% |
| Remuneration and social security | 454/9 | €6,893 | €9,647 | +€2,754 | +40.0% |
| Other amounts payable | 47/48 | €512,606 | €600,312 | +€87,706 | +17.1% |
| Accrued charges and deferred income | 492/3 | €4,590 | - | -€4,590 | |
| Remuneration, social security and pensions | 62 | €58,983 | €73,055 | +€14,072 | +23.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €60,752 | €62,422 | +€1,670 | +2.7% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | - | €27,997 | +€27,997 | |
| Other operating charges | 640/8 | - | €8 | +€8 | |
| Gross operating margin | 9900 | €269,261 | €274,101 | +€4,840 | +1.8% |
| Operating profit (loss) | 9901 | €149,526 | €110,620 | -€38,906 | -26.0% |
| Financial income | 75/76B | €1,143 | €1,466 | +€322 | +28.2% |
| Recurring financial income | 75 | €1,143 | €1,466 | +€322 | +28.2% |
| Financial charges | 65/66B | €20,908 | €17,570 | -€3,338 | -16.0% |
| Recurring financial charges | 65 | €20,908 | €17,570 | -€3,338 | -16.0% |
| Profit (loss) for the period before taxes | 9903 | €129,761 | €94,516 | -€35,246 | -27.2% |
| Income taxes | 67/77 | €42,706 | €34,663 | -€8,043 | -18.8% |
| Profit (loss) for the period | 9904 | €87,055 | €59,853 | -€27,202 | -31.2% |
| Profit (loss) for the period to be appropriated | 9905 | €87,055 | €59,853 | -€27,202 | -31.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.